news

Cailianshe News, August 11 (Editor: Ruoyu)According to incomplete statistics from Cailianshe, the second half of the year has so far includedShenyang Chemical、Zhongqingbao、Tongde Chemical、Ren Zixing、ST East, Huiyu Pharmaceutical,Fudan Fuhua、Sunsea Intelligent、Yongjin Shares, Jinfu Technology,ST Gaohong、Puli Pharmaceutical12 A-share listed companies including announced that their companies or related parties were filed. See the figure below for details:

From the perspective of secondary market performance,The day after the announcement, Fudan Fuhua, Sunsea Intelligent, ST Gaohong and Puli Pharmaceutical all hit the daily limit., Yongjin shares closed at the limit down.

▌Four A-share listed companies received notices of filing by the China Securities Regulatory Commission on Friday night for suspected violations of information disclosure laws and regulations. Zhongqingbao, the "first online game stock", was among them

Tongde Chemical, whose main businesses are civil explosives, non-civil explosives BDO-PBAT chemical business, and power generation business, announced on Friday evening that it had recently received a "Notice of Filing of a Case" issued by the China Securities Regulatory Commission.The CSRC decided to file a case against the company because it was suspected of violating laws and regulations in information disclosure. The company announced on the same day that it had received the "Administrative Supervision Measures Decision" from the Shanxi Regulatory Bureau.Upon investigation, the company hasInformation disclosure is not timely, some insider information is not registered, etc.In the secondary market, Tongde Chemical's stock price has fallen by 39.47% since its peak on January 4.

Renzixing, which focuses on the field of network security and is deeply involved in cyberspace data governance, announced on the same day thatThe China Securities Regulatory Commission decided to file a case against the company due to suspected illegal information disclosureAfter self-examination by the company, the reason for filing this case was mainly due to the company's self-examination finding thatThe wholly-owned subsidiary Beijing Yahong Century Technology Development Co., Ltd. had overstated assets, overstated revenues, and overstated profits in the relevant years.The company has actively carried out rectification, corrected accounting errors and made retroactive adjustments to the relevant annual financial statements, and hired an accounting firm to issue relevant audit reports. In the secondary market, Ren Zixing's stock price has fallen by more than 51% since the beginning of the year.

Zhongqingbao, the "first online game stock", announced on the same day that the company and its actual controller Zhang Yunxia recently received a "Notice of Filing of a Case" issued by the China Securities Regulatory Commission.The company and its actual controller Zhang Yunxia are suspected of violating laws and regulations in information disclosure. The China Securities Regulatory Commission has decided to file a case against the company and its actual controller Zhang Yunxia.At present, all production and operation activities of the company are proceeding normally. It is worth noting thatAt the end of July, Zhongqingbao was punished by the regulatory authorities for information disclosure violations.The actual controller of the company, Zhang Yunxia, ​​was taken coercive measures last year, but the company concealed the information for nearly 8 months. It was not until Zhang Yunxia received the "Decision on Non-Prosecution" and the "Decision on Removal of Bail Pending Trial" that the relevant information was disclosed, and the company was punished by the regulatory authorities.Since its peak in January, Zhongqingbao's stock price has fallen by nearly 40%. Back in 2021, the company's stock price had a maximum increase of 4.47 times from September to November of that year.

Shenyang Chemical, a subsidiary of China National Chemical Corporation, which mainly engages in polyether, paste resin, acrylic acid and ester businesses, announced on the same day thatBecause the company was suspected of violating laws and regulations in information disclosure, the China Securities Regulatory Commission decided to file a case against the company.At present, the company's production and operation activities are proceeding normally. In the secondary market, Shenyang Chemical's stock price has fallen by 50.8% since its peak in early January this year.

Other A-share listed companies that received notices of filing by the China Securities Regulatory Commission this week include ST Dongshi, Huiyu Pharmaceutical and Fudan Fuhua. ST Dongshi, whose main business is motor vehicle driver training and civil aircraft pilot training, announced on August 8 thatOn August 7, 2024, the actual controller of the company, Xu Xiong, received a "Notice of Filing" issued by the China Securities Regulatory Commission and was investigated for suspected illegal and irregular information disclosure.Xu Xiong has served as the chairman of ST Dongshi and executive director and general manager of Oriental Fashion Investment since 2005.In 2023, he was approved for arrest on suspicion of manipulating the securities market.In fact,In the first half of this year, ST Dongshi repeatedly exposed information disclosure violations, all of which were related to Xu Xiong.Due to the failure to disclose the freezing of shares in a timely manner, the Shanghai Stock Exchange issued a regulatory warning to the controlling shareholder and actual controller of ST Dongshi on March 15. In the secondary market, the largest cumulative decline in ST Dongshi's stock price since its peak in March is 83.14%.

Huiyu Pharmaceutical, which focuses on the research, development, production and domestic and overseas sales of innovative drugs and high-quality generic drugs in the field of tumor treatment, announced on August 5 that the companyChairman and General Manager Ding Zhao received a notice of investigation from the China Securities Regulatory Commission on August 5 for suspected short-term trading of the company's stocks.This matter is an investigation of Ding Zhao personally and will not have a significant impact on the operation of the company's board of directors and the company's daily business activities. Huiyu Pharmaceutical disclosed the "Announcement on Short-term Trading and Apology by Relatives of Directors and Senior Management" on April 30. Ding Zhao's mother Yan Zhao engaged in short-term trading from August 23, 2023 to September 27, 2023.All the proceeds of 192,100 yuan will be turned over to the companyIn the secondary market, Huiyu Pharmaceutical's share price hit a record low in early February this year, with the largest cumulative decline since the beginning of the year being 38.74%.

also,Fudan Fuhua's stock price fell to the limit the day after the case was filedFudan Fuhua, which mainly engages in software development, biomedicine, and science and technology park industries, announced on August 5 thatBecause the company was suspected of violating laws and regulations in information disclosure, the China Securities Regulatory Commission decided to file a case against the company.Fudan Fuhua received an administrative supervision measure decision letter from the Shanghai Securities Regulatory Bureau on March 19. After investigation, it was found that the company concealed liabilities, falsely settled accounts, and improperly confirmed accounting between 2013 and 2017, which led to the disclosure ofThe periodic financial reports for the period 2013-2023 contained false statements, in violation of relevant regulations.In the filing announcement, Fudan Fuhua stated that the company's production and operation are currently normal. In the long run, the largest cumulative decline in Fudan Fuhua's stock price since the beginning of the year is 53.28%.